Home
About
What We Do
Who we are
Advisors
Partners
Our name
Equality, diversity & Inclusion
Products
Products
ProMatrix BioDerm
ProMatrix GroDerm
Pipeline
Products for Research
Wounds and treatments
Skin-loss wounds
How wounds heal
Current wound treatments
Chronic wounds
Technology
Tissue Scaffolds
ProMatrix technology
Manufacturing platform
Modelling & Digital twin
New Cover Page
Research Services
News
INVESTORS
contact

www.oxartis.co.uk

Home
About
What We Do
Who we are
Advisors
Partners
Our name
Equality, diversity & Inclusion
Products
Products
ProMatrix BioDerm
ProMatrix GroDerm
Pipeline
Products for Research
Wounds and treatments
Skin-loss wounds
How wounds heal
Current wound treatments
Chronic wounds
Technology
Tissue Scaffolds
ProMatrix technology
Manufacturing platform
Modelling & Digital twin
New Cover Page
Research Services
News
INVESTORS
contact
Julian Dye
November 15, 2022

Oxartis joins the Panacea Stars Develop Accelerator

Julian Dye
November 15, 2022

We are honoured and delighted to be selected for the Oxford-based Panacea Stars Accelerator Programme, running through November and December 2022. We have already participated in an entrepreneurs bootcamp, and gained many insights from formal talks and mentoring sessions.

Newer PostOXARTIS WINS BIOKICKSTART COMPETITION
Older PostOxartis selected for the TechTour Health21 Season
Back to Top

Oxartis Limited Registered Office: 30 Upper High Street, Thame, Oxfordshire, OX9 3EZ